Duloxetine (Cymbalta): a new SNRI for depression. Med Lett Drugs Ther. 2004 Oct;46(1193):81-82. PMID: 15480298
Ferguson JM. Depression: diagnosis and management for primary care physicians. J Clin Psychiatry. 2000 Oct;2(5):173-178
Depont F, Rambelomanana S, Le Puil S, et al. Antidepressants: psychiatrists' opinions and clinical practice [abstract]. Acta Psychiatr Scan. 2003 Jul;108(1):24-31. PMID: 12807374
Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA. 2001 Oct;98(22):12796-12801. PMID: 11675510
Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet. 2000 Mar;355(9207):911-918. PMID: 10752718
Kasper S, Olié JP. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression [abstract]. Eur Psychiatry. 2002 Jul;17(Suppl 3):331-340. PMID: 15177089
Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med. 2000 Dec;343(26):1942-4950. PMID: 11136266
Waintraub L, Septein L, Azoulay P. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine [abstract]. CNS Drugs. 2002;16(1):65-75. PMID: 11772119
Sonawalla S, Chakraborty N, Parikh R. Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India. J Indian Med Assoc. 2003 Feb;101(2):116-117,124. PMID: 12841497
Rush AJ. Mood disorders: treatment of depression. In: Sadock BJ, et al. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2009
Ministry of Health Singapore. Depression. MOH (Singapore). http://www.moh.gov.sg. Mar 2004
Institute for Clinical Systems Improvement (ICSI). Major depression in adults in primary care. http://bit.ly/Depr0512. May 2012.
Institute for Clinical Systems Improvement (ICSI). Health care guideline: major depression in adults for mental health care providers. http://www.icsi.org. 2002.
National Institute of Mental Health. Depression. http://www.nimh.gov. 2002.
National Collaborating Centre for Mental Health. The treatment and management of depression in adults. NICE. http://www.nice.org.uk. Oct 2009. Accessed 14 Jan 2011.
American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Psychiatryonline. http://psychiatryonline.org. Oct 2010.
American Psychiatric Association. Depressive disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:155-188.
Bauer M, Pfennig A, Severus E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013 Jul;14(5):334-385. doi: 10.3109/15622975.2013.804195. PMID: 23879318
Bauer M, Severus E, Kohler S, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry. 2015 Feb;16(2):76-95. doi: 10.3109/15622975.2014.1001786. PMID: 25677972
Trangle M, Gursky J, Haight R, et al. Adult depression in primary care. Institute for Clinical Systems Improvement (ICSI). http://www.icsi.org. Mar 2016.
Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016 Sep;61(9):540-560. doi: 10.1177/0706743716659417. Accessed 10 May 2017. PMID: 27486148
Parikh SV, Quilty LC, Ravitz P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. psychological treatments. Can J Psychiatry. 2016 Sep;61(9):524-539. doi: 10.1177/0706743716659418. PMID: 27486150
Gitlin M. Unipolar depression in adults: treatment with lithium. UpToDate. https://www.uptodate.com. 14 Oct 2020.
Hirsch M, Birnbaum R. Atypical antidepressants: pharmacology, administration, and side effects. UpToDate. https://www.uptodate.com. 04 Dec 2020. Accessed 18 Dec 2020.
Hirsch M, Birnbaum R. Tricyclic and tetracyclic drugs: pharmacology, administration, and side effects. UpToDate. https://www.uptodate.com. 03 Dec 2020. Accessed 18 Dec 2020.
National Institute for Health and Care Excellence. Implanted vagus nerve stimulation for treatment-resistant depression. NICE. https://www.nice.org.uk. 12 Aug 2020.
National Institute for Health and Care Excellence. Depression in children and young people: identification and management. NICE. https://www.nice.org.uk. 25 Jun 2019.
Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 changes on the national survey on drug use and health [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). Jun 2016 . Accessed 15 Oct 2020.
Thase MT, Connolly KR. Ketamine and esketamine for treating unipolar depression in adults: administration, efficacy, and adverse effects. UpToDate. https://www.uptodate.com. 26 Aug 2020.
Thase MT, Connolly KR. Unipolar depression in adults: choosing treatment for resistant depression. UpToDate. https://www.uptodate.com. 14 Nov 2020. Accessed 18 Dec 2020.
Williams J, Nieuwsma J. Screening for depression in adults. UpToDate. https://www.uptodate.com. 26 Jun 2020. Accessed 18 Dec 2020.
Baldwin D. Generalized anxiety disorder in adults: epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate. www.uptodate.com. 3 Apr 2018. Accessed 21 Oct 2020.
Ministry of Health Malaysia. Management of major depressive disorder (second edition). MOH Malaysia. https://www.moh.gov.my. Jun 2019. Accessed 05 Feb 2021 .
Anxiety and Depression Association of America. Clinical practice review for major depressive disorder. ADAA. https://www.adaa.org. Nov 2020.
Lyness JM. Unipolar depression in adults: assessment and diagnosis. UpToDate. https://www.uptodate.com. 16 Sep 2019. Accessed 18 Dec 2020.
McQuaid JR, Lin EH, Barber JP, et al. Clinical practice guideline for
the treatment of depression across three age cohorts American
Psychological Association guideline development panel for
the treatment of depressive disorders. American Psychology Association. https://www.apa.org. Feb 2019.
Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network
for Mood and Anxiety Treatments (CANMAT) 2016
clinical guidelines for the management of adults with
major depressive disorder: section 4. Neurostimulation
treatments. Can J Psychiatry. 2016 Sep;61(9):561-575. doi: 10.1177/0706743716660033. Accessed 29 May 2019. PMID: 27486154
Simon G, Rush AJ. Unipolar major depression in adults: choosing
initial treatment. UpToDate. https://www.uptodate.com. 18 Nov 2020. Accessed 18 Dec 2020.
Chan JWY, Lam SP, Li SX, et al. Adjunctive bright light treatment with gradual advance in unipolar major depressive disorder with evening chronotype - a randomized controlled trial. Psychol Med. 2020 Sep;14:1-10. doi: 10.1017/S0033291720003232. PMID: 32924897
Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): part II. Treatment and ongoing management. Pediatrics. 2018 Mar;14(3):e20174082. doi: 10.1542/peds.2017-4082.
Gitlin M. Unipolar depression in adults and initial treatment: investigational and nonstandard approaches. UpToDate. https://ww.uptodate.com/. 03 Jan 2020.
Gottlieb JF, Benedetti F, Geoffroy PA, et al. The chronotherapeutic treatment of bipolar disorders: a systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology. Bipolar Disord. 2019 Dec;21(8):741-773. doi: 10.1111/bdi.12847. PMID: 31609530
Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry. 2021;55(1):7-117. doi: 10.1177/0004867420979353.
Wirz-Justice A, Benedetti F, Berger M, et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med. 2005 Jul;35(7):939-944. doi: 10.1017/s003329170500437x. PMID: 16045060
Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for the management of major depressive disorder. http://www.healthquality.va.gov. Apr 2016.
Nelson C. Unipolar depression in adults: treatment with second-generation antipsychotics. UpToDate. https://www.uptodate.com. 27 Aug 2020.
Rush AJ. Unipolar major depression in adults: choosing initial treatment. UpToDate. https://www.uptodate.com. 18 Nov 2020.
Fox ME, Lobo MK. The molecular and cellular mechanisms of depression: a focus on reward circuitry. Mol Psychiatry. 2019 Dec;24(12):1798-1815. doi: 10.1038/s41380-019-0415-3. PMID: 30967681
Krishnan R. Unipolar depression: Pathogenesis. UpToDate. https://www.uptodate.com/. 13 Sep 2022.
Krishnan R. Unipolar depression: Neurobiology. UpToDate. https://www.uptodate.com/. 31 Aug 2022.
Lyness JM. Unipolar depression in adults: Assessment and diagnosis. UpToDate. https://www.uptodate.com/. 26 Sep 2022.
National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management. NICE. https://www.nice.org.uk/. 29 Jun 2022.
Tian H, Hu Z, Xu J, et al. The molecular pathophysiology of depression and the new therapeutics. MedComm (2020). 2022 Jul;3(3):e156. doi: 10.1002/mco2.156. PMID: 35875370
World Health Organization (WHO). Depression. WHO. https://www.who.int. 13 Sep 2021.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2022.
